Kneu Health

Country:
UK
Founding year:
2022

Kneu Health is a neurotechnology company developing a digital platform designed to assess and monitor neurological function through continuous, objective measurement. The company focuses on capturing movement, motor control, and related physiological signals to quantify neurological status and recovery over time.

Its system combines wearable sensors with analytics software to generate quantitative metrics of motor performance and functional change. These measurements are intended to complement traditional clinical assessments by providing high-frequency, real-world data outside of episodic clinical visits.

Kneu Health’s technology is positioned for use in rehabilitation, neurology, and research settings, particularly for monitoring recovery after neurological injury or disease. The company frames its platform as an objective measurement and monitoring layer rather than a diagnostic imaging or neuromodulation system.

Tools and Infrastructure
Monitoring
Clinical Workflows

Neurofounders Insights

Modality:
Biomarkers
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Parkinson's
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Seed

Kneu Health is positioned around objective neurological monitoring through wearable and software-based data capture, targeting recovery and disease progression tracking. Its promise lies in digitizing longitudinal neurological assessment, though its competitive moat appears more workflow-based than modality-driven.

Related companies

Articles featuring

Kneu Health

No articles yet!

Press releases

No press releases published yet.